In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Greg Herrema On Thermo Fisher Scientific Following Customers In Asia: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

A new plant by Thermo Fisher Scientific Inc. to produce dry powder media used in the manufacture of biologic drugs in Singapore that matches the capacity and specs of its U.S.-based operations is another sign that Asia is on the roadmap for multinational biologics firms. Greg Herrema, president for biosciences at the company, sat down with PharmAsia News to talk about how the company sees the market in this region.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC085159

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel